Anabolic-androgenic steroids affect the content of substance P and substance P1-7 in the rat brain

Peptides

Volumn 21, Issue 6, 2000, Pages 845-852

  Hallberg, Mathias ^a   Johansson, Pia ^a   Kindlundh, Anna M S ^a   Nyberg, Fred ^a  

^a Div Biol Res Drug Dependence   (Sweden)

Author keywords

Aggression; Anabolic androgenic steroids; Brain; N terminal fragment; Rat; Substance P

Indexed keywords

ANABOLIC AGENT; NANDROLONE DECANOATE; SUBSTANCE P;

AGGRESSION; AMINO TERMINAL SEQUENCE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HYPOTHALAMUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANABOLIC AGENTS; ANDROGENS; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MALE; NANDROLONE; PEPTIDE FRAGMENTS; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; TISSUE DISTRIBUTION;

EID: 0033849393     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00218-7     Document Type: Article

References (48)

1. Bahrke M.S., Yesalis C.E., Wright J.E. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An Update. Sports Med. 22:1996;367-390.
2. Bijlsma J.W., Duursma S.A., Thijssen J.H., Huber O. Influence of nandrolondecanoate on the pituitary-gonadal axis in males. Acta Endocrinol. 101:1982;108-112.
3. A receptors in the rat. Horm Behav. 27:1993;568-583.
4. Bochnia M., Medras M., Pospiech L., Jaworska M. Poststeroid balance disorder-a case report in a body builder. Int J Sports Med. 20:1999;407-409.
5. Bourne A., Barnes K., Taylor B.A., Turner A.J., Kenny A.J. Membrane peptidases in the pig choroid plexus and on other cell surfaces in contact with the cerebrospinal fluid. Biochem J. 259:1989;69-80.
6. Brodin E., Rosén A., Schött E., Brodin K. Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions. Neuropeptides. 26:1994;253-260.
7. Cabasso A. Peliosis hepatis in a young adult bodybuilder. Med Sci Sports Exerc. 26:1994;2-4.
8. Choi P.Y.L., Pope H.G. Violence toward women and illicit androgenic anabolic steroid use. Ann Clin Psychiatry. 6:1994;21-25.
9. Conacher G.H., Workman D.G. Violent crime possibly associated with anabolic steroid use. Am J Psychiatry. 146:1989;679.
10. De Felipe C, Herrero JF, O′Brien JA, Palmer JA, Doyle CA, Smith AJH, Laird JMA, Belmonte C, Cervero F, Hunt SP. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998;392:394-7.
11. De Palatis L.R., Khorram O., McCann S.M. Age-, sex-, and gonadal steroid-related changes in immunoreactive substance P in the rat anterior pituitary gland. Endocrinology. 117:1985;1368-1373.
12. Deutch A.Y., Maggio J.E., Bannon M.J., Kalivas P.W., Tam S.-Y., Goldstein M., Roth R.H. Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides. 6:1985;113-122.
13. Eriksson U., Andrén P.E., Caprioli R.M., Nyberg F. Reversed-phase HPLC combined with tandem mass spectrometry in studies of a substance P-converting enzyme from human cerebrospinal fluid. J Chromatogr A. 743:1996;213-220.
14. Hall M.E., Stewart J.M. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release. Pharmacol Biochem Behav. 41:1992;75-78.
15. Herrera-Marschitz M., Terenius L., Sakurada T., Reid M.S., Ungerstedt U. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain. Brain Res. 521:1990;316-320.
16. Huston J.P., Hasenöhrl R.U., Boix F., Gerhardt P., Schwarting R.K.W. Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity. Psychopharmacol. 112:1993;147-162.
17. Johansson P., Ray A., Zhou Q., Huang W., Karlsson K., Nyberg F. Anabolic androgenic steroids increase β-endorphin levels in the ventral tegmental area in the male rat brain. Neuroscience Res. 27:1997;185-189.
18. Johansson P., Hallberg M., Kindlundh A., Nyberg F. The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate. Brain Res Bull. 51:2000;413-418.
19. A receptors in dopamine agonist-induced behavior and neuropeptide gene expression. Brain Res. 836:1999;99-109.
20. Karler R., Calder L.D., Thai L.M., Bedingfield J.B. The dopaminergic, glutaminergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res. 671:1995;100-104.
21. Kelley A.E., Cador M., Stinus L. Behavioral analysis of the effect on substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology. 85:1985;37-46.
22. Kindlundh A.M.S., Isacson D.G.L., Berglund L., Nyberg F. Doping among high school students in Uppsala, Sweden A presentation of the attitudes, distribution, side effects, and extent of use . Scand J Soc Med. 26:1998;71-74.
23. Kindlundh A.M.S., Isacson D.G.L., Berglund L., Nyberg F. Factors associated with adolescent use of doping agents anabolic-androgenic steroids . Addiction. 94:1999;543-553.
24. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-722.
25. Kramer M.S., Cutler N., Feighner F., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knoweles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
26. Kreeger J.S., Larson A.A. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice. Eur J Pharmacol. 238:1993;111-115.
27. Maggio J.E. Tachykinins. Ann Rev Neurosci. 11:1988;13-28.
28. Mantyh P.W., Hunt S.P., Maggio J.E. Substance P receptors localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand . Brain Res. 307:1984;147-165.
29. Mewis C., Spyridopoulos I., Kuhlkamp V., Seipel L. Manifestation of severe coronary heart disease after anabolic drug use. Clin Cardiol. 19:1996;153-155.
30. Nikulina E.M., Marchand J.E., Miczek K.A., Kream R.M. Social defeat stress induces enhanced opioid analgesia and neurochemical changes in rat periaqueductal grey. Soc Neurosci Abstr. 23:1997;126.
31. Persson S., Post C., Holmdahl R., Nyberg F. Decreased neuropeptide-converting enzyme activities in cerebrospinal fluid during acute but not chronic phases of collagen induced arthritis in rats. Brain Res. 581:1992;273-282.
32. Persson S., Le Grevés P., Thörnvall M., Eriksson U., Silberring J., Nyberg F. Neuropeptide converting and processing enzymes in the spinal cord and cerebrospinal fluid. Prog Brain Res. 104:1995;111-130.
33. Reid M.S., Herrera-Marschitz M., Hökfeldt T., Lindefors M., Persson H., Ungerstedt U. Striatonigral GABA, dynorphin, substance P, and neurokinin. A modulation of nigrostriatal dopamine release evidence for direct regulatory mechanisms . Exp Brain Res. 82:1990;293-303.
34. Scott D.M., Wagner J.C., Barlow T.W. Anabolic steroid use among adolescents in Nebraska schools. Am J Health Syst Pharm. 53:1996;2068-2072.
35. Sharma H.S., Nyberg F., Olsson Y., Dey P.K. Alteration of substance P after trauma to the spinal cord an experimental study in the rat . Neuroscience. 38:1990;205-212.
36. Siegel A., Roeling T.A.P., Gregg T.R., Kruk M.R. Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev. 23:1999;359-389.
37. Siegel A., Schubert K., Shaiku M.B. Neurochemical mechanisms underlying amygdaloid modulation of aggressive behaviour in cat. Agg Behav. 21:1995;49-62.
38. Smith G.S.T., Savery D., Marden C., Costa J.J.L., Averill S., Priestley J.V., Rattray M. Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat. J Comp Neurology. 350:1994;23-40.
39. Smith S.T., Stackman R.W., Clark A.S. Spatial working memory is preserved in rats treated with anabolic-androgenic steroids. Brain Res. 737:1996;313-316.
40. Su T.P., Pagliaro M., Scmidt P.J., Pickar D., Wolkowitz O., Rubinow D.R. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 269:1993;2760-2764.
41. Tanner S.M., Miller D.W., Alongi C. Anabolic steroid use by adolescents Prevalence, motives, and knowledge of risk . Clin J Sport Med. 5:1995;108-115.
42. Thiblin I., Finn A., Ross S.B., Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activites in the male rat brain following long-term treatment with anabolic androgenic steroids. Br J Pharmacol. 126:1999;1301-1306.
43. Tomaz C., Nogueira P.J.C. Facilitation of memory by peripheral administration of substance P. Behav Brain Res. 83:1997;143-145.
44. Watling K.J., Krause J.E. The rising sun shines on substance P and related peptides. Trends Pharmacol Sci. 14:1993;81-84.
45. Wilson J.D., Griffin J.E. The use and misuse of androgens. Metabolism. 29:1980;1278-1295.
46. Wilson J.D. Androgen abuse by athlets. Endocr Rev. 9:1988;181-199.
47. Yao R., Rameshwar P., Donnelly R.J., Siegel A. Neurokinin-1 expression and co-localization with glutamate and GABA in the hypothalamus of the cat. Mol Brain Res. 71:1999;149-158.
48. Yukhananov R.Y., Larson A.A. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neurosci Lett. 178:1994;163-166.